Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

被引：3

作者：

Iskierka-Jazdzewska, Elzbieta ^{[1
]}

Kim, Won Seog ^{[2
]}

Cho, Seok-Goo ^{[3
]}

Kim, Tae Min ^{[4
]}

Jarque, Isidro ^{[5
]}

Robak, Tadeusz ^{[6
]}

Poon, Michelle ^{[7
]}

Prince, H. Miles ^{[8
,9
]}

Yong, Sung ^{[10
]}

Lim, Francesca ^{[11
]}

Carpio, Cecilia ^{[12
]}

Tan, Tran-Der ^{[13
]}

Ayyappan, Sabarish ^{[14
]}

Gutierrez, Antonio ^{[15
]}

Zhang, Huilai ^{[16
]}

Cao, Junning ^{[17
,18
]}

Zhang, Mingzhi ^{[19
,20
]}

Tessoulin, Benoit ^{[21
,22
]}

Li, Jingjin ^{[23
]}

Ivanescu, Cristina ^{[24
]}

机构：

[1] Med Univ Lodz, Copernicus Mem Hosp, Lodz, Poland

[2] Samsung Med Ctr, Ctr Hematol Malignancy, Seoul, South Korea

[3] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[5] Hosp Univ La Fe, Valencia, Spain

[6] Med Univ Lodz, Lodz, Poland

[7] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore

[8] Epworth Healthcare, Melbourne, Vic, Australia

[9] Univ Melbourne, Melbourne, Vic, Australia

[10] Dong A Univ Hosp, Busan, South Korea

[11] Singapore Gen Hosp, Singapore, Singapore

[12] Vall DHebron Hosp, Barcelona, Spain

[13] Koo Fdn Sun Yat Sen Canc Ctr, Taipei, Taiwan

[14] Univ Iowa Hosp & Clin, Iowa City, IA USA

[15] Hosp Univ Son Espases, IdISBa Palma, Palma de Mallorca, Spain

[16] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China

[17] Fudan Univ, Dept Lymphoma, Shanghai Canc Ctr, Shanghai, Peoples R China

[18] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China

[19] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[20] Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Peoples R China

[21] Nantes Univ, Sch Med, Nantes, France

[22] Univ Hosp Nantes, Nantes, France

[23] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[24] IQVIA, Amsterdam, Netherlands

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180743

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[31] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
Dyer, Martin J. S.
De Vos, Sven
Ruan, Jia
Flowers, Christopher
Maddocks, Kami J.
Rule, Simon
Hamdy, Ahmed M.
Izumi, Raquel
Slatter, J. Greg
Cheung, Jean
Frigualt, Melanie M.
Wei, Helen
Mourya, Sanchita
Hunder, Naomi N. H.
Fowler, Nathan Hale
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[32] Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
Cheng, Rebecca
Scippa, Kayla
Locke, Frederick L.
Snider, Julia Thornton
Jim, Heather
ONCOLOGY AND THERAPY, 2022, 10 (01) : 123 - 141
[33] Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
Rebecca Cheng
Kayla Scippa
Frederick L. Locke
Julia Thornton Snider
Heather Jim
Oncology and Therapy, 2022, 10 : 123 - 141
[34] Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
Assouline, Sarit E.
Nielsen, Torsten Holm
Yu, Stephen
Alcaide, Miguel
Chong, Lauren
MacDonald, David
Tosikyan, Axel
Kukreti, Vishal
Kezouh, Abbas
Petrogiannis-Haliotis, Tina
Albuquerque, Marco
Fornika, Daniel
Alamouti, Sepideh
Froment, Remi
Greenwood, Celia M. T.
Oros, Kathleen Klein
Camglioglu, Errol
Sharma, Ayushi
Christodoulopoulos, Rosa
Rousseau, Caroline
Johnson, Nathalie
Crump, Michael
Morin, Ryan D.
Mann, Koren K.
BLOOD, 2016, 128 (02) : 185 - 194
[35] Associations between sexuality, body image and health-related quality of life in patients treated for diffuse large B-cell lymphoma: A cross-sectional study
Olsson, Cecilia
Larsson, Maria
Eklund, Anna Josse
Ringner, Anders
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2024, 73
[36] Phase 1/2 Trial of Acalabrutinib Plus Pembrolizumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 9 - 10
[37] Health-related quality of life (HRQOL) burden in patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) and non-Hodgkin's lymphoma (RR-NHL).
Lin, Vincent
Oak, Bhagyashree
Snider, Julia
Epstein, Josh
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[38] A Phase 2 Clinical Trial of SGN-40 Monotherapy in Relapsed Diffuse Large B-Cell Lymphoma.
Advani, Ranjana
De Vos, Sven
Ansell, Stephen M.
Kahl, Brad
Cheson, Bruce D.
Bartlett, Nancy L.
Furman, Richard R.
Winter, Jane N.
Kaplan, Henry
Dornan, David
Whiting, Nancy
Drachman, Jonathan
Forero-Torres, Andres
BLOOD, 2008, 112 (11) : 368 - 368
[39] Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Kim, Tae Min
Taszner, Michal
Cho, Seok-Goo
Novelli, Silvana
Le Gouill, Steven
Poon, Michelle Limei
Villasboas, Jose C.
Champion, Rebecca
Bachy, Emmanuel
Guidez, Stephanie
Alonso, Aranzazu Alonso
Jagadeesh, Deepa
Merli, Michele
Tucker, David
Cai, Jingxian
De Oliveira, Carolina Leite
Zhu, Min
Chaudhry, Aafia
Mohamed, Hesham
Ambati, Srikanth R.
Luminari, Stefano
BLOOD, 2022, 140 : 2280 - 2282
[40] A phase 2 study of polatuzumab vedotin plus bendamustine plus rituximab in relapsed/refractory diffuse large B-cell lymphoma
Terui, Yasuhito
Rai, Shinya
Izutsu, Koji
Yamaguchi, Motoko
Takizawa, Jun
Kuroda, Junya
Ishikawa, Takayuki
Kato, Koji
Suehiro, Youko
Fukuhara, Noriko
Ohmine, Ken
Goto, Hideki
Yamamoto, Kazuhito
Kanemura, Nobuhiro
Ueda, Yasunori
Ishizawa, Kenichi
Kumagai, Kyoya
Kawasaki, Atsuko
Saito, Tomohisa
Hashizume, Misato
Shibayama, Hirohiko
CANCER SCIENCE, 2021, 112 (07) : 2845 - 2854

← 1 2 3 4 5 →